Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

ClinicalTrials.gov ID: NCT02972632

Public ClinicalTrials.gov record NCT02972632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Single-Arm, Multicenter, Prospective, Phase 4, Interventional, Flexible Dose Study to Evaluate the Effectiveness of Vortioxetine on Goal Achievement After a Change in Antidepressant Medication for the Treatment of Subjects With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the effectiveness of treatment with vortioxetine on participant goal achievement after a change in antidepressant medication for the treatment of major depressive disorder (MDD).

Study identification

NCT ID
NCT02972632
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Takeda
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 22, 2016 (Actual)
Primary completion
Feb 6, 2018 (Actual)
Completion
Feb 6, 2018 (Actual)
Last update posted
Jul 11, 2019

2016 – 2018

United States locations

U.S. sites
25
U.S. states
11
U.S. cities
25
Facility City State ZIP Site status
ATP Clinical Research, Inc. Costa Mesa California 92626 —
ProScience Research Group Culver City California 90230 —
Behavioral Research Specialists, LLC Glendale California 91206 —
Pacific Research Partners Oakland California 94607 —
Excell Research Oceanside California 92056 —
Anderson Clinical Research Redlands California 92374 —
University Medical Group Upland California 91207 —
MCB Clinical Research Centers, LLC Colorado Springs Colorado 80910 —
Suncoast Clinical Research Inc. New Port Richey Florida 34652 —
Behavioral Clinical Research , Inc North Miami Florida 33162 —
Compass Research Main Orlando Florida 32806 —
University of South Florida Tampa Florida 33613 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Baber Research Group Naperville Illinois 60563 —
Deaconess Clinic Evansville Indiana 47713-1227 —
Novex Clinical Research, LLC New Bedford Massachusetts 2740 —
Coastal Research Associates, Inc. South Weymouth Massachusetts 2190 —
University of Michigan, Ann Arbor Ann Arbor Michigan 48109 —
Columbia University Medical Center New York New York 10023 —
Dayton Clinical Research Dayton Ohio 45406 —
Green & Seidner Family Practice Associates Lansdale Pennsylvania 19446 —
Relaro Medical Trials Dallas Texas 75243 —
Red Oak Psychiatry Associates, PA Houston Texas 77090 —
Radiant Research, Inc. San Antonio Texas 78229 —
Family Psychiatry of The Woodlands The Woodlands Texas 77381 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02972632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02972632 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →